About Portfolio
BioSynthesis: Advancing Biotechnology for a Sustainable Future
BioSynthesis is a biotech company focused on synthetic biology solutions to address environmental and health challenges. They engineer microorganisms to produce bio-based materials, pharmaceuticals, and renewable chemicals. BioSynthesis’s platform, SynBioLab, enables efficient genetic engineering and bioprocessing, accelerating the development of sustainable alternatives to petrochemicals.
With applications in industries like agriculture, healthcare, and manufacturing, BioSynthesis is pioneering eco-friendly solutions that reduce dependency on fossil fuels and promote sustainable practices.
Key Focus Areas
Sustainable Bio-Production: BioSynthesis creates renewable chemicals and materials to replace petrochemicals, supporting the transition to a green economy.
Pharmaceutical Innovation: The company develops microbial solutions for producing pharmaceuticals and biologics, making treatments more accessible.
Founders of BioSynthesis
Dr. Elena Orlov (CEO & Co-Founder): A biochemist and environmentalist, Dr. Orlov is passionate about using biotechnology to create sustainable solutions.
Markus Fischer (CTO & Co-Founder): Markus’s expertise in genetic engineering drives BioSynthesis’s synthetic biology breakthroughs.
Investment Impact
With funding from EcoBiotech Ventures, BioSynthesis has expanded its SynBioLab platform, increasing its production capacity and expanding its portfolio to include biofuels and biodegradable plastics, furthering its mission of environmental stewardship.
Statistics